Vera Knäuper

Dr. Vera Knäuper

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
VKVera Knäuper
Vera Knäuper
CLCarlos López-Otin
Carlos López-Otin
BSBryan Smith
Bryan Smith
GKGraham Knight
Graham Knight
GMGillian Murphy
Gillian Murphy
The cDNA of a novel matrix metalloproteinase, collagenase-3 (MMP-13) has been isolated from a breast tumor library (Freije, J. M. P., Diez-Itza, I., Balbin, M., Sanchez, L. M., Blasco, R., Tolivia, J., and López-Otin, C.(1994) J. Biol. Chem. 269, 16766-16773), and a potential role in tumor progression has been proposed for this enzyme. In order to establish the possible role of collagenase-3 in connective tissue turnover, we have expressed and purified recombinant human procollagenase-3 and characterized the enzyme biochemically. The purified procollagenase-3 was shown to be glycosylated and displayed a M of 60,000, the N-terminal sequence being LPLPSGGD, which is consistent with the cDNA-predicted sequence. The proenzyme was activated by p-aminophenylmercuric acetate or stromelysin, yielding an intermediate form of M 50,000, which displayed the N-terminal sequence LEVTGK. Further processing resulted in cleavage of the Glu-Tyr peptide bond to the final active enzyme (M 48,000). Trypsin activation of procollagenase-3 also generated a Tyr N terminus, but it was evident that the C-terminal domain was rapidly lost, and hence the collagenolytic activity diminished. Analysis of the substrate specificity of collagenase-3 revealed that soluble type II collagen was preferentially hydrolyzed, while the enzyme was 5 or 6 times less efficient at cleaving type I or III collagen. Fibrillar type I collagen was cleaved with comparable efficiency to the fibroblast and neutrophil collagenases (MMP-1 and MMP-8), respectively. Unlike these collagenases, gelatin and the peptide substrates Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH and Mca-Pro-Cha-Gly-Nva-His-Ala-Dpa-NH were efficiently hydrolyzed as well, as would be predicted from the similarities between the active site sequence of collagenase-3 (MMP-13) and the gelatinases A and B. Active collagenase-3 was inhibited in a 1:1 stoichiometric fashion by the tissue inhibitors of metalloproteinases, TIMP-1, TIMP-2, and TIMP-3. These results suggest that in vivo collagenase-3 could play a significant role in the turnover of connective tissue matrix constituents.

1 July 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
VKVera Knäuper
Vera Knäuper
HWHorst Will
Horst Will
CLCarlos López-Otin
Carlos López-Otin
BSBryan Smith
Bryan Smith
SASusan J. Atkinson
Susan J. Atkinson
GMGillian Murphy
Gillian Murphy
Gelatinase A and membrane-type metalloproteinase (MT1-MMP) were able to process human procollagenase-3 (Mr 60,000) to the fully active enzyme (Tyr85 N terminus; Mr 48,000). MT1-MMP activated procollagenase-3 via a Mr 56,000 intermediate (Ile36 N terminus) to 48,000 which was the result of the cleavage of the Glu84-Tyr85 peptide bond. We have established that the activation rate of procollagenase-3 by MT1-MMP was enhanced in the presence of progelatinase A, thereby demonstrating a unique new activation cascade consisting of three members of the matrix metalloproteinase family. In addition, procollagenase-3 can be activated by plasmin, which cleaved the Lys38-Glu39 and Arg76-Cys77 peptide bonds in the propeptide domain. Autoproteolysis then resulted in the release of the rest of the propeptide domain generating Tyr85 N-terminal active collagenase-3. However, plasmin cleaved the C-terminal domain of collagenase-3 which results in the loss of its collagenolytic activity. Concanavalin A-stimulated fibroblasts expressing MT1-MMP and fibroblast-derived plasma membranes were able to process human procollagenase-3 via a Mr 56,000 intermediate form to the final Mr 48,000 active enzyme which, by analogy with progelatinase A activation, may represent a model system for in vivo activation. Inhibition experiments using tissue inhibitor of metalloproteinases, plasminogen activator inhibitor-2, or aprotinin demonstrated that activation in the cellular model system was due to MT1-MMP/gelatinase A and excluded the participation of serine proteinases such as plasmin during procollagenase-3 activation. We have established that progelatinase A can considerably potentiate the activation rate of procollagenase-3 by crude plasma membrane preparations from concanavalin A-stimulated fibroblasts, thus confirming our results using purified progelatinase A and MT1-MMP. This new activation cascade may be significant in human breast cancer pathology, where all three enzymes have been implicated as playing important roles.

11 September 1998 in FEBS Letters
Verified
Journal Article
Closed access
AAAugustin Amour
Augustin Amour
PSPatrick M Slocombe
Patrick M Slocombe
AWAilsa Webster
Ailsa Webster
MBMichael Butler
Michael Butler
CKC.Graham Knight
C.Graham Knight
GMGillian Murphy
Gillian Murphy

1 March 1999 in APMIS
Verified
Journal Article
Closed access
PDF file
GMGillian Murphy
Gillian Murphy
HSHeather Stanton
Heather Stanton
SCSusan Cowell
Susan Cowell
GBGeorgina Butler
Georgina Butler
VKVera Knäuper
Vera Knäuper
JGJelena Gavrilovic
Jelena Gavrilovic

12 May 2000 in FEBS Letters
Verified
Journal Article
Closed access
AAAugustin Amour
Augustin Amour
CKC.Graham Knight
C.Graham Knight
AWAilsa Webster
Ailsa Webster
PSPatrick M. Slocombe
Patrick M. Slocombe
PSPaul E. Stephens
Paul E. Stephens
GMGillian Murphy
Gillian Murphy

12 February 1996 in FEBS Letters
Verified
Journal Article
Closed access
AFAmanda Fosang
Amanda Fosang
KLKarena Last
Karena Last
VKVera Knäuper
Vera Knäuper
GMGillian Murphy
Gillian Murphy
PNPeter J. Neame
Peter J. Neame